GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

FHS
June 21, 2024
3:08 am

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

WestGene wins FDA nod to study mRNA vaccine to treat certain cancers – Pharmaceutical Technology

Chinese biotech WestGene announced an FDA approval for its mRNA therapeutic cancer vaccine. Credit: aslysun via Shutterstock. The US Food and Drug Administration (FDA) has

May 10, 2024

Family violence found to have severe long-term health effects

A new synthesis of global evidence highlights a strong connection between family violence and long-term health consequences, significantly impacting the psychological and physical well-being of

October 29, 2024

Low vitamin D tied to belly fat and weak muscles in women

Low vitamin D in women is linked to more belly fat and lower muscle mass. The study suggests using waist-to-height ratio and muscle mass index

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.